Psychedelic drugs
Search documents
Lilly Buys Psychedelic Drugmaker AtaiBeckley for $3.8 Billion
Bloomberg Television· 2026-07-16 14:23
What exactly is Lilly buying with this thing, Madison. So Lilly is buying into this fast growing psychedelic space, which was once really on the fringes of drug development, but has gotten a lot more interesting and a lot more interest from drug makers over the last year or so. There are now a couple of companies that are nearing potentially FDA approval.They're in late stages of testing. AtaiBeckley is moving into late stages of testing. They have their lead drug is called BPL zero zero three.It's actually ...